Effects of Depression and Selective Serotonin Reuptake Inhibitor Use on Adherence to Highly Active Antiretroviral Therapy and on Clinical Outcomes in HIV-Infected Patients
Michael A. Horberg(Kaiser Permanente), Drew Kovach(Kaiser Permanente), Miguel Mogyoros(Kaiser Permanente), Michael J. Silverberg(Kaiser Permanente), Leo B. Hurley(Kaiser Permanente), Winkler G. Weinberg(Kaiser Permanente), Diana Antoniskis(Kaiser Permanente), Robert Dobrinich(Kaiser Permanente), William Towner(Kaiser Permanente), Daniel B. Klein(Kaiser Permanente San Leandro Medical Center), Susan Bersoff‐Matcha(Kaiser Permanente), Charles Price Quesenberry(Kaiser Permanente), Wayne T. Dodge(Kaiser Permanente)
Cited by 267
Related Papers
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
|JAMA Network Open|2020|614
Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2013|496
Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2016|441
Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada
|AIDS Research and Human Retroviruses|2015|335